Abstract: Disclosed herein are bicycloaryl compounds of Formula (I) that selectively modulate nuclear receptors, preferably the androgen receptor, or a pharmaceutically acceptable salt, ester, amide, or prodrug thereof, and methods of treating disease comprising administering a compound of Formula (I) to a patient in need thereof.
Type:
Application
Filed:
June 28, 2007
Publication date:
January 10, 2008
Applicant:
Acadian Pharmaceuticals, Inc.
Inventors:
Nathalie Schlienger, Jan Pawlas, Alma Fejzic, Roger Olsson, Birgitte Lund, Fabrizio Badalassi, Rasmus Lewinsky, Mikkel Thygesen